Roslin Technologies are experts in animal cell culture and offer a broad portfolio of services around animal cell technology. We offer, as a service, access and processing of many animal cell types for clients in vitro research activities as well as working with collaborators and commercial partners to develop in vitro bioassays and therapies. A major driver is our inducible pluripotent stem cells (iPS) platform which focuses on developing cell lines for therapeutic screening assays, toxicology, clean-meat technology, cell therapy and gene editing studies. These validated iPS cell lines can be differentiated into a range of animal cell types providing broad application.
Contact us to discuss any of your animal cell research needs or commercial requirements.